Search results for : ca4 - Cancerrxgene - Genomics of Drug Sensitivity in Cancer

Search Results for: ca4

Drugs (2)
Celllines ( 6)
Genetic Features (4)

Name	Synonyms	Targets	Target Pathway	PubCHEM	Datatset	Sample size	Screening site
PFI-3	BDF00016096	PB1, SMARCA4, SMARCA2	Chromatin other	78243717	GDSC1	834	SANGER
PFI3	PFI-3, PFI 3, AOB2221	Polybromo 1, SMARCA4, SMARCA2	Chromatin other	78243717	GDSC2	894	SANGER

Name	Cell Model Passport Link	COSMIC ID	Tissue	Tissue sub-type
CA46	SIDM00907	910703	UNCLASSIFIED	Blood
CA46	SIDM00907	910703	UNCLASSIFIED	Blood
OVCA420	SIDM00967	1480364	OV	Urogenital system
OVCA420	SIDM00967	1480364	OV	Urogenital system
OVCA433	SIDM00966	1480367	OV	Urogenital system
OVCA433	SIDM00966	1480367	OV	Urogenital system

Feature Name	Feature Type
SMARCA4_mut	coding variant
cnaBRCA42	copy number alteration (loss)
cnaBRCA47	copy number alteration (gain)
cnaBRCA48	copy number alteration (gain)

The Genomics of Drug Sensitivity in Cancer Project is a collaboration between the Cancer Genome Project at the Wellcome Sanger Institute (UK) and the Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center (USA). This work is funded by Wellcome.

Users have a non-exclusive, non-transferable right to use data files for internal proprietary research and educational purposes, including target, biomarker and drug discovery. Excluded from this licence are use of the data (in whole or any significant part) for resale either alone or in combination with additional data/product offerings, or for provision of commercial services.
Please note: The data files are experimental and academic in nature and are not licensed or certified by any regulatory body. Genome Research Limited provides access to data files on an “as is” basis and excludes all warranties of any kind (express or implied).